β-Amyloid induces nuclear protease-mediated lamin fragmentation independent of caspase activation

Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1189-99. doi: 10.1016/j.bbamcr.2016.02.008. Epub 2016 Feb 10.

Abstract

β-Amyloid (Aβ), a hallmark peptide of Alzheimer's disease, induces both caspase-dependent apoptosis and non-apoptotic cell death. In this study, we examined caspase-independent non-apoptotic cell death preceding caspase activation in Aβ42-treated cells. We first determined the optimal treatment conditions for inducing cell death without caspase activation and selected a double-treatment method involving the incubation of cells with Aβ42 for 4 and 6 h (4+6 h sample). We observed that levels of lamin A (LA) and lamin B (LB) were reduced in the 4+6 h samples. This reduction was decreased by treatment with suc-AAPF-CMK, an inhibitor of nuclear scaffold (NS) protease, but not by treatment with z-VAD-FMK, a pan-caspase inhibitor. In addition, suc-AAPF-CMK decreased the changes in nuclear morphology observed in cells in the 4+6 h samples, which were different from nuclear fragmentation observed in STS-treated cells. Furthermore, suc-AAPF-CMK inhibited cell death in the 4+6 h samples. LA and LB fragmentation occurred in the isolated nuclei and was also inhibited by suc-AAPF-CMK. Together, these data indicated that the fragmentation of LA and LB in the Aβ42-treated cells was induced by an NS protease, whose identity is not clearly determined yet. A correlation between Aβ42 toxicity and the lamin fragmentation by NS protease suggests that inhibition of the protease could be an effective method for controlling the pathological process of AD.

Keywords: Alzheimer's disease; Apoptosis; Caspase; Lamin; Nuclear scaffold protease; β-amyloid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / pharmacology*
  • Caspase Inhibitors / pharmacology
  • Caspases / metabolism
  • Cell Death / drug effects
  • Dose-Response Relationship, Drug
  • Endopeptidases / metabolism*
  • Enzyme Activation
  • HeLa Cells
  • Humans
  • Immunoblotting
  • Lamin Type A / metabolism*
  • Lamin Type B / metabolism*
  • Microscopy, Confocal
  • Peptide Fragments / pharmacology*
  • Protease Inhibitors / pharmacology
  • Staurosporine / pharmacology
  • Time Factors

Substances

  • Amyloid beta-Peptides
  • Caspase Inhibitors
  • Lamin Type A
  • Lamin Type B
  • Peptide Fragments
  • Protease Inhibitors
  • Endopeptidases
  • Caspases
  • lamin proteinase
  • Staurosporine